These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 25975443)
21. [Current strategies in the treatment of advanced stage mantle cell lymphoma]. Lenz G; Dreyling M; Unterhalt M; Hiddemann W Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247 [TBL] [Abstract][Full Text] [Related]
22. Treatment strategies in mantle cell lymphoma. Maddocks K; Blum KA Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613 [TBL] [Abstract][Full Text] [Related]
23. Current regimens and novel agents for mantle cell lymphoma. Chen Y; Wang M; Romaguera J Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852 [TBL] [Abstract][Full Text] [Related]
24. Mantle cell lymphoma - Current standards of care and future directions. Martin P; Ghione P; Dreyling M Cancer Treat Rev; 2017 Jul; 58():51-60. PubMed ID: 28651117 [TBL] [Abstract][Full Text] [Related]
25. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study. Lefrère F; Delmer A; Suzan F; Levy V; Belanger C; Djabarri M; Arnulf B; Damaj G; Maillard N; Ribrag V; Janvier M; Sebban C; Casasnovas RO; Bouabdallah R; Dreyfus F; Verkarre V; Delabesse E; Valensi F; McIntyre E; Brousse N; Varet B; Hermine O Leukemia; 2002 Apr; 16(4):587-93. PubMed ID: 11960337 [TBL] [Abstract][Full Text] [Related]
38. High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients. van 't Veer MB; de Jong D; MacKenzie M; Kluin-Nelemans HC; van Oers MH; Zijlstra J; Hagenbeek A; van Putten WL Br J Haematol; 2009 Feb; 144(4):524-30. PubMed ID: 19036081 [TBL] [Abstract][Full Text] [Related]
39. Management of mantle cell lymphoma in the elderly: current and potential strategies. Vignon M; Venon MD; Hermine O; Delarue R Drugs Aging; 2013 Dec; 30(12):979-86. PubMed ID: 24178346 [TBL] [Abstract][Full Text] [Related]
40. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. Howard OM; Gribben JG; Neuberg DS; Grossbard M; Poor C; Janicek MJ; Shipp MA J Clin Oncol; 2002 Mar; 20(5):1288-94. PubMed ID: 11870171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]